Cincinnati Specialty Underwriters Insurance CO Makes New $3.73 Million Investment in Lam Research Corporation $LRCX

Cincinnati Specialty Underwriters Insurance CO acquired a new stake in shares of Lam Research Corporation (NASDAQ:LRCX) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 27,830 shares of the semiconductor company’s stock, valued at approximately $3,726,000. Lam Research makes up 0.9% of Cincinnati Specialty Underwriters Insurance CO’s investment portfolio, making the stock its 23rd largest position.

Several other institutional investors and hedge funds have also modified their holdings of LRCX. Baader Bank Aktiengesellschaft lifted its stake in Lam Research by 109.8% in the third quarter. Baader Bank Aktiengesellschaft now owns 14,911 shares of the semiconductor company’s stock valued at $1,953,000 after buying an additional 7,805 shares in the last quarter. Wealthstream Advisors Inc. acquired a new stake in shares of Lam Research during the third quarter worth $222,000. Rockland Trust Co. acquired a new stake in shares of Lam Research during the third quarter worth $353,000. Wealthfront Advisers LLC lifted its position in Lam Research by 6.7% in the 3rd quarter. Wealthfront Advisers LLC now owns 128,132 shares of the semiconductor company’s stock valued at $17,157,000 after acquiring an additional 8,096 shares in the last quarter. Finally, Navellier & Associates Inc. boosted its stake in Lam Research by 1,437.8% in the 3rd quarter. Navellier & Associates Inc. now owns 34,600 shares of the semiconductor company’s stock worth $4,633,000 after purchasing an additional 32,350 shares during the period. 84.61% of the stock is currently owned by institutional investors and hedge funds.

Lam Research News Roundup

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Multiple analyst upgrades and higher price targets reinforce upside expectations (Sanford C. Bernstein raised its target to $285; other outlets bumped targets to the mid‑$200s), supporting investor confidence. Bernstein Adjusts Price Target on Lam Research
• Positive Sentiment: Industry and fundamentals view: commentary highlights strong AI/memory-driven demand, solid margins and $5B‑plus quarter potential — arguments used to justify a premium multiple. High P/E: Justified Premium or Too Pricey?
• Neutral Sentiment: Technical signal: LRCX recently crossed above its 20‑day moving average, which can attract momentum traders but is a short‑term indicator. 20-Day Moving Average Crossover
• Negative Sentiment: Insider selling: Director Eric Brandt sold 35,000 shares (~$7.9M), trimming his stake — a signal that can trigger short‑term investor caution even if not unusual for insiders to diversify. Director Sells 35,000 Shares
• Negative Sentiment: Leadership/strategic concern: reporting on a leadership shift and the CEA‑Leti alliance prompted questions about whether recent multiple expansion is fully justified, creating valuation uncertainty for some investors. Leadership Shift And CEA Leti Alliance
• Negative Sentiment: Options flow: unusually large put buying (roughly +112% vs. average) indicates elevated hedging or bearish positioning, which can amplify downside pressure in the near term.

Insider Activity

In other Lam Research news, CFO Douglas R. Bettinger sold 40,080 shares of the company’s stock in a transaction that occurred on Friday, November 14th. The stock was sold at an average price of $150.60, for a total value of $6,036,048.00. Following the sale, the chief financial officer owned 987,237 shares in the company, valued at $148,677,892.20. This represents a 3.90% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Eric Brandt sold 35,000 shares of the firm’s stock in a transaction that occurred on Friday, February 6th. The shares were sold at an average price of $225.60, for a total value of $7,896,000.00. Following the completion of the sale, the director directly owned 253,705 shares of the company’s stock, valued at approximately $57,235,848. The trade was a 12.12% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Company insiders own 0.31% of the company’s stock.

Analysts Set New Price Targets

LRCX has been the topic of several recent research reports. BNP Paribas Exane lifted their price target on Lam Research from $80.00 to $140.00 and gave the company a “neutral” rating in a research note on Thursday, October 23rd. Morgan Stanley increased their price objective on Lam Research from $211.00 to $244.00 and gave the stock an “equal weight” rating in a report on Thursday, January 29th. Summit Insights raised Lam Research from a “hold” rating to a “buy” rating in a research report on Thursday, January 29th. New Street Research boosted their target price on Lam Research from $195.00 to $235.00 and gave the company a “neutral” rating in a research note on Friday, January 30th. Finally, Stifel Nicolaus raised their price target on shares of Lam Research from $250.00 to $280.00 and gave the stock a “buy” rating in a research note on Thursday, January 29th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-eight have given a Buy rating and six have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $244.88.

Lam Research Trading Down 1.2%

NASDAQ LRCX opened at $226.61 on Wednesday. Lam Research Corporation has a 12 month low of $56.32 and a 12 month high of $251.87. The company has a current ratio of 2.26, a quick ratio of 1.61 and a debt-to-equity ratio of 0.37. The stock has a 50 day moving average of $197.23 and a 200-day moving average of $152.89. The company has a market cap of $282.98 billion, a PE ratio of 46.44, a PEG ratio of 2.46 and a beta of 1.78.

Lam Research (NASDAQ:LRCX) last issued its earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 earnings per share for the quarter, topping analysts’ consensus estimates of $1.17 by $0.10. The business had revenue of $5.34 billion for the quarter, compared to the consensus estimate of $5.23 billion. Lam Research had a net margin of 30.22% and a return on equity of 62.81%. The firm’s revenue for the quarter was up 22.1% on a year-over-year basis. During the same period in the previous year, the company earned $0.91 earnings per share. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. On average, equities research analysts anticipate that Lam Research Corporation will post 3.71 EPS for the current fiscal year.

Lam Research Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, April 8th. Stockholders of record on Wednesday, March 4th will be issued a $0.26 dividend. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date of this dividend is Wednesday, March 4th. Lam Research’s dividend payout ratio is presently 21.31%.

About Lam Research

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.